ENOBIA PHARMA
Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments.
ENOBIA PHARMA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1997-01-01
Address:
Montreal, Quebec, Canada
Country:
Canada
Website Url:
http://www.enobia.com
Total Employee:
1001+
Status:
Active
Contact:
+1 203-272-2596
Email Addresses:
[email protected]
Total Funding:
158.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Amazon CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Allied Urological Services
Allied Urological Services develops advanced technologies for the treatment of kidney stones and other urological disorders.
Coppola lab
Coppola Lab specializes in the genetic architecture of neuropsychiatric disorders.
Endeau
Endeau is developing enabling technology for the routine performance of Water Aided Endoscopy.
Immplacate
Immplacate is a preclinical stage cell therapy company.
MNG Laboratories
MNG is your source for Neurogenetic Answers with a reputation for going beyond the expected to make a difference for patient care.
Molecular Medicine BioServices
Molecular Medicine BioServices has the experience, facility, and service focus to be your trusted source for process R&D.
Sight Pharma Inc.
Sight Pharma develops novel therapies for oncology and cardiovascular diseases in collaboration with universities.
Targeted Medical Pharma
Targeted Medical Pharma develops therapeutic systems for the nutritional management of chronic diseases.
Current Advisors List
Current Employees Featured
Investors List
CTI Capital
CTI Capital investment in Series C - Enobia Pharma
Desjardins Venture Capital
Desjardins Venture Capital investment in Series C - Enobia Pharma
OrbiMed
OrbiMed investment in Series C - Enobia Pharma
Lothian Partners
Lothian Partners investment in Series C - Enobia Pharma
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series B - Enobia Pharma
Lothian Partners
Lothian Partners investment in Series B - Enobia Pharma
Fonds de solidaritรฉ FTQ
Fonds de solidaritรฉ FTQ investment in Series B - Enobia Pharma
Desjardins Venture Capital
Desjardins Venture Capital investment in Series B - Enobia Pharma
OrbiMed
OrbiMed investment in Series B - Enobia Pharma
T2C2 Capital
T2C2 Capital investment in Series A - Enobia Pharma
Official Site Inspections
http://www.enobia.com
- Host name: 164.90.244.158
- IP address: 164.90.244.158
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013